CA1151548A - Pressure-sensitive adhesive containing iodine - Google Patents
Pressure-sensitive adhesive containing iodineInfo
- Publication number
- CA1151548A CA1151548A CA000354628A CA354628A CA1151548A CA 1151548 A CA1151548 A CA 1151548A CA 000354628 A CA000354628 A CA 000354628A CA 354628 A CA354628 A CA 354628A CA 1151548 A CA1151548 A CA 1151548A
- Authority
- CA
- Canada
- Prior art keywords
- iodine
- sensitive adhesive
- pressure
- adhesive
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/12—Iodine, e.g. iodophors; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/58—Adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00655—Plasters adhesive
- A61F2013/0071—Plasters adhesive containing active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/106—Halogens or compounds thereof, e.g. iodine, chlorite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
Abstract
Abstract A process for making a stable chemical complex of iodine, an iodide ion and a dermatologically acceptable room temperature tacky pressure-sensitive adhesive which is substantially free of acidic components. The resulting composition exhibits broad-spectrum antimicrobial activity when placed in contact with mammalian skin and is useful in or on tapes, drapes, and other medical devices.
Description
A PRESSURE-SENSITIVE ~DHESIVE
CONTAINING IODINE
This invention relates to a process for making dermatologically acceptable pressure-sensitive adhesive containing iodine. An aspect of this invention relates to the ability of the resulting composition to exhibit anti-septic broad-spectrum antimil~robial activity in a controlled and sustained manner.
Numerous pathogens are present on the human skin. In a hospital environment it is generally desired that the growth of disease-producing microorganisms be inhibited and preferably that these microorganisms be destroyed so as to control patient infection and encourage wound healing. As a result, the application to the skin surface of topical bactericidally active agents has become a standard part of the aseptic hospital technique.
One often used antimicrobial agent is iodine but because of its inherent chemical and physical limitations, its use as an antiseptic broad-spectrum antimicrobial has been limited. Elemental iodine has a high vapor pressure which causes great loss in germicidal potency as the iodine content volatilizes from antiseptic preparations containing iodine as the antimicrobial agent. Moreover, iodine is generally not occluded with bandages because of potential for corrosive destruction of skin.
In order to preserve the antimicrobial activity of iodine and at the same time reduce the corrosive properties and vapor pressure, complexes of polyvinyl-pyrrolidone and iodine have been formed. An example of the synthesis of one such polyvinylpyrrolidone-iodine complex (PVP-I) is disclosed in U.S. Patent 4,128,633.
The topical applications of broad-spectrum antimicrobials have been in the form of preoperative skin preps, surgical scrub tissues, e.g. U.S. Patent 4,045,364, washes, wound cleaners r lotions and ointments. In some instances such a delivery is effective for the particular ,. ,~.
:
5~8 purpose for a limited period of time. Microorganisms that may have survived the initial application of the antimicrobial agent act as a seed -to cause -the pathogen population in some instances to rise to their initial levels. Contin-uous application of an antimicrobial agent to the site is a means of inhibiting the increase in population.
While numerous other biologically active agen-ts have been incorporated into adhesive layers on a substrate to provide a continuous application to the body of the agent, there has been no successful incorporation of a broad-spectrum antimicrobial into an adhesive layer which has been characterized by stability and unaltered activity of the broad-spectrum antimicrobial. Examples of various other agents that have been incorporated into adhesives are United States Patent 2,137,169 where phenol, thymol, menthol, e-tc. are added to a starch adhesive; United States Patent 3,249,109 where benzocaine was added to a tacky gelatin; United States Patent 3,632,740 where a corticosteroid is added to an adhesive; United States Patent 3,734,097 where a microencapsulated anti-neoplastic agent is added to an adhesive; United States Patent 4,073,291 where Tretinoin is added to an adhesive; United States Patent 3,769,071 where 5-fluorouracil is incorporated into an adhesive; and United States Patent 3,896,789 where retinoic acid is incorporated into a pressure sensitive tape.
Previous attempts at incorporating broad-spectrum antimicrobials into adhesives have~been frustrated by reduced biological activity, and uncontrollable release which causes skin irritation in some patients.
The term broad-spectrum is used herein to mean that the antimicrobial exhibits activity against more than one type of microorganism, i.e. both gram positive and gram negative bacteria and would very likely also have activity against fungi and viruses (Reference: Federal Register, Vol. 39, No. 179).
The present invention provides a process for making a composition which exhibits controlled and sustained antiseptic broad-spectrum antimicrobial 9~-~ --2--.~
activity when placed in contact with the skin comprising forming a solution of an iodide, a solvent and iodine, and reacting said solution with a dermato-logically acceptable pressure-sensitive adhesive.
The present invention may be generally described as a process for the formation of a chemical and storage .. ~
- 2a -: .
;, ' .
- : :
5~8 stable composition which when placed in contact with the skin uniformly and controllably releases the broad-spectrum antimicrobial agent iodine. This release occurs with substantially unalterecl broad-spectrum antimicrobial activity even after being subjected to irradiation sterilization. This antiseptic antimicrobial activity is accomplished by the present invention with essentially no skin irritation.
The resulting composition of the process of the present invention is a stable chemical complex oE iodine, an iodide ion and a dermatologically acceptable normally room temperature tacky pressure sensitive adhesive (PSA).
By "stable" it is meant that a composition coating of 11 grains per 24 sq. in. which is attached to a polyethylene sheet can be exposed to a temperature of 120F and a relative humidity of 9~ for two (2) weeks or to a dose of
CONTAINING IODINE
This invention relates to a process for making dermatologically acceptable pressure-sensitive adhesive containing iodine. An aspect of this invention relates to the ability of the resulting composition to exhibit anti-septic broad-spectrum antimil~robial activity in a controlled and sustained manner.
Numerous pathogens are present on the human skin. In a hospital environment it is generally desired that the growth of disease-producing microorganisms be inhibited and preferably that these microorganisms be destroyed so as to control patient infection and encourage wound healing. As a result, the application to the skin surface of topical bactericidally active agents has become a standard part of the aseptic hospital technique.
One often used antimicrobial agent is iodine but because of its inherent chemical and physical limitations, its use as an antiseptic broad-spectrum antimicrobial has been limited. Elemental iodine has a high vapor pressure which causes great loss in germicidal potency as the iodine content volatilizes from antiseptic preparations containing iodine as the antimicrobial agent. Moreover, iodine is generally not occluded with bandages because of potential for corrosive destruction of skin.
In order to preserve the antimicrobial activity of iodine and at the same time reduce the corrosive properties and vapor pressure, complexes of polyvinyl-pyrrolidone and iodine have been formed. An example of the synthesis of one such polyvinylpyrrolidone-iodine complex (PVP-I) is disclosed in U.S. Patent 4,128,633.
The topical applications of broad-spectrum antimicrobials have been in the form of preoperative skin preps, surgical scrub tissues, e.g. U.S. Patent 4,045,364, washes, wound cleaners r lotions and ointments. In some instances such a delivery is effective for the particular ,. ,~.
:
5~8 purpose for a limited period of time. Microorganisms that may have survived the initial application of the antimicrobial agent act as a seed -to cause -the pathogen population in some instances to rise to their initial levels. Contin-uous application of an antimicrobial agent to the site is a means of inhibiting the increase in population.
While numerous other biologically active agen-ts have been incorporated into adhesive layers on a substrate to provide a continuous application to the body of the agent, there has been no successful incorporation of a broad-spectrum antimicrobial into an adhesive layer which has been characterized by stability and unaltered activity of the broad-spectrum antimicrobial. Examples of various other agents that have been incorporated into adhesives are United States Patent 2,137,169 where phenol, thymol, menthol, e-tc. are added to a starch adhesive; United States Patent 3,249,109 where benzocaine was added to a tacky gelatin; United States Patent 3,632,740 where a corticosteroid is added to an adhesive; United States Patent 3,734,097 where a microencapsulated anti-neoplastic agent is added to an adhesive; United States Patent 4,073,291 where Tretinoin is added to an adhesive; United States Patent 3,769,071 where 5-fluorouracil is incorporated into an adhesive; and United States Patent 3,896,789 where retinoic acid is incorporated into a pressure sensitive tape.
Previous attempts at incorporating broad-spectrum antimicrobials into adhesives have~been frustrated by reduced biological activity, and uncontrollable release which causes skin irritation in some patients.
The term broad-spectrum is used herein to mean that the antimicrobial exhibits activity against more than one type of microorganism, i.e. both gram positive and gram negative bacteria and would very likely also have activity against fungi and viruses (Reference: Federal Register, Vol. 39, No. 179).
The present invention provides a process for making a composition which exhibits controlled and sustained antiseptic broad-spectrum antimicrobial 9~-~ --2--.~
activity when placed in contact with the skin comprising forming a solution of an iodide, a solvent and iodine, and reacting said solution with a dermato-logically acceptable pressure-sensitive adhesive.
The present invention may be generally described as a process for the formation of a chemical and storage .. ~
- 2a -: .
;, ' .
- : :
5~8 stable composition which when placed in contact with the skin uniformly and controllably releases the broad-spectrum antimicrobial agent iodine. This release occurs with substantially unalterecl broad-spectrum antimicrobial activity even after being subjected to irradiation sterilization. This antiseptic antimicrobial activity is accomplished by the present invention with essentially no skin irritation.
The resulting composition of the process of the present invention is a stable chemical complex oE iodine, an iodide ion and a dermatologically acceptable normally room temperature tacky pressure sensitive adhesive (PSA).
By "stable" it is meant that a composition coating of 11 grains per 24 sq. in. which is attached to a polyethylene sheet can be exposed to a temperature of 120F and a relative humidity of 9~ for two (2) weeks or to a dose of
2.5 megarads of gamma irradiation without substantial alteration of the physical appearance or of the chemical activity, as tested by the starch test and microbiological activity as tested by Zone Inhibition Assay.
The Zone Inhibition Assay test is performed as follows: An assay bacterium Bacillus subtilis is grown in rotary shake culture (200 rpm) for approxiamtely 6 hours at 37C. The growth medium, L-broth, consist of the following ingredients dissolved in 1 L of distilled water and adjusted to pH 7.0: tryptone 10 g, yeast extract 5 g, sodium chloride 10 g, glucose 1 g. This culture is diluted in sterile L-broth to 50% T @ 660 mu, further diluted 1:10, and inoculated at a ratio of 1:100 into molten soybean-casein digest agar medium (Inolex) maintained at 45-50C. Assay plates are prepared by first pipesetting a 5 ml base layer of soybean-casein digest agar medium (TSA), allowing this to harden at room temperature in disposable petri dishes, and then overlaying with 5 ml of seeded TSA. These preparations are used the same day.
, .
~51~8 Coated polyethylene films (prepared in the manner taught in the Example below) are tested in the same way regardless of the antimicrobial incorporated into the adhesive layer. Ten o mm discs are cut from an evenly coated area (i.e. no visible flaws) with a heavy duty paper punch (Master Products, Series 25). The paper backing is removed from the coated disc with the aid of forceps and microspatula. The coated disc is then placed adhesive-side down on the seeded-agar surface, 4 per plate.
Iodine reference discs are then prepared. A
solution containing 10 percent iodine is prepared by dissolving 1 g of iodine and 1 g of sodium iodide in 10 percent aqueous acetone using a 10 ml volumetric flask.
This stock solution, freshly prepared and the same solvent is used to prepare 0.~5, 0.5, 0.75 and 1.0 percent iodine solutions. From these dilutions, 10 uI aliquots are applied to 6 mm polyester fabric discs placed on the seeded agar surface to provide discs containing 25, 50, 75 and 100 ug iodine each. IThe polyester fabric should be leached overnight in solvent to remove inherent antibacterial activity prior to punching ) Each reference disc is covered with a 1 inch square of 2-ml polyethylene to prevent vaporization prior to diffusion through the underlying agar.
The coated discs and reference disc assay plates are incubated overnight at room temperature. Zones of inhibition around the discs were measured to the nearest 0.5 mm with the aid of a binocular stereoscopic microscope. In the case of iodine antimicrobials, the coated discs are also removed to examine plates for areas of growth inhibition under the discs.
Assay results for reference antimicrobials using the preceding methods demonstrate that the diameter of the zone of inhibition measured in mm is linearly proportional to LOGlo concentration for each agent over the range examined. The release of antimicrobial from the adhesive S41~
of the present invention can be estimated by graphic interpolation oE the inhibition values.
The starch test is performed as follows: An dicator solution is prepared by dissolving 62.5 g of .i " ~`~ qd~ ~
~ Iodine Titration Indicator (Eastern Chemical, Division of Guardian Chemical Corp., Hauppauge, N~) is dissolved in 250 ml of distilled water with stirring. A
drop of the Paragon Indicator solution from then is placed on the adhesive surface. Formation of blue coloration in the drop indicates availability of iodine.
The process for forming the composition of the present invention involves forming a pressure sensitive adhesive and mixing into it an antimicrobial treating solution comprising iodine, an iodide, and a solvent. The resulting composition preferably contains N-vinyl-pyrrolidone (NVP) in the backbone of the pressure-sensitive adhesive which serves to complex iodine. It is believed that complexation provides stability while maintaining an appropriate equilibrium to provide sustained release of iodine.
The composition which is the resulting chemical complex of the aforementioned process is stable, non-irritating, non-sensitizing, non-toxic and non-trauma-tizing to skin or other tissues. Although it is generally recognized that an acid medium renders many broad-spectrum antimicrobial agents more stable, i.e.
PVP-I, it has been found that a pressure sensitive adhesive having a significant acidic content causes a negative alteration in the stability of iodine in the present system. Therefore it is desirable that the normally room temperature tacky pressure-sensitive adhesive monomers which is to act as the base of the present composition be substantially free of acidic components. By "substantially free of acidic components"
it is meant that the pressure-sensitive adhesive monomers be substantially free of substituent groups which exhibit acid functionality, e.g., acrylic acid~ etc. Examples of ~ f~fJ,cfe M,3~k s~
adhesive monomer which can be utilized in the preparation present antimicrobial composition PSA include acrylics and vinyl/acrylics. The formulation of these adhesives are well known in the art, e.g. U.S. Patents RE 24906, 2,973,286, 3,307,544, 3,728,148, etc. It will be appreciated by one skilled in the art that the aforestated adhesive types might also include various chemical modifiers so as to enable them to have the utility dictated by the situation, e.y. tackifiers, crosslinkers, stabili2ers, initiators etc. The preferred pressure sensitive adhesive for use in this invention is a copolymer comprised of N-vinylpyrrolidone (NVP) and isooctyl acrylate (IOA).
It is believed that the iodine release is controlled by the copolymerization of low levels of the NVP into the adhesive backbone. The iodine release from the adhesive matrix is a function of the level of NVP
copolymerized into the adhesive backbone. For a given iodine content, the higher the NVP level, the lower the antimicrobial activity~ For this invention, the useful NVP comonomer level is less than 30% (preferentially 5-10%) of the total adhesive solids. At higher ~VP
levels, skin adhesion and antimicrobial activity are - reduced.
An antimicrobial solution is used to incorporate iodine into the pressure sensitive adhesive. This solution contains iodine, inorganic iodide (e.g., potassium iodide) and a suitable solvent compatible with the adhesive. A solution recommended for use with the 5-10% NVP copolymer adhesive above would have a ~.5:1 to 4:1 molar ratio of iodide:iodine dissolved in denatured ethanol (preferred solution, 2:1 molar ratio of iodide:iodine). For example, a solution utilizing sodium iodide would have a formulation of 1-20 wt.% iodine, 1.2-24 wt.~; sodium iodide and 97.8-56 wt.% ethanol.
Although the mechanism of complexation of iodine into the aclhesive matrix of this invention is not 15~8 completely understood, it is believed to have some analogy to the complexation of iodine with polyvinylpyrrolidone.
The following is one possible representation of the complex of the present invention:
5 / IOR ~ ~ ~ C=~ ~ OR ~ ¦ ~ C=o~
C=OI N ~ ~1 C=o~
~CH2-CH-~L - -CH2-CH---/ CH2-CH-~ CH2-CH~
where m, n, o and p are integers.
The composition of the process of the present invention may be either attached directly onto a flexible backing substrate or ~ormed onto a release liner for later use. The backing may be any material known for use in medical application with the preferred material being polyethylene film. The solvents are then evaporated by means known to the art whereby an adhesive film is formed which is useable in or on tapes, drapes and other medical 15 devices.
The invention is further illustrated by the following non-limiting example:
A solution polymer adhesive of composition isooctyl acrylate/N-vinylpyrrolidone/ -methacryloxypropyl trimethoxysilane (94.95/5/0.05) is prepared by polymeriza-tion in ethyl acetate/heptane/ethanol (48/47/5) (Conditions: nitrogen atmosphere, azobisisobutyronitrile initiator, 6 hours at 53C; Properties: total solids =
45%, intrinsic viscosity = 0.8).
25 The following formulation is prepared:
adhesive from above 500 g.
a solution containing 20 wt.% iodine/24 wt.%
sodium iodide in denatured ethanol 11 g.
additional denatured ethanol 78 g.
30 a 10 wt.% solution of p-toluenesulfonic acid (p-TSA) in denatured ethanol (0.1 wt.%
p-TSA on adhesive solids) 2.3 g.
5~8 The formulation is stirred at room temperature with a spatula to yield a uniform solution of 1 wt.% iodine/1.2 wt.% sodium iodide on adhesive solids. This solution is coated onto a silicone release liner and dried (10 min., 175F) to form a homogeneous, iodine-colored adhesive film of coating weight equal to 11 grains/24 sq. in. The adhesive film is laminated to a backing of a corona and quatarnary amine antistat treated polyethylene to form a construction containing the antimicrobial iodine. This construction exhibited an activity when applied in vivo on seeded human skin of a four ~4) log reduction of Staph~lococcus aureus and Pseudomonas aeruginosa after one hour. The construction exhibited satisfactory adhesion and stability after sterilization by irradiation.
The Zone Inhibition Assay test is performed as follows: An assay bacterium Bacillus subtilis is grown in rotary shake culture (200 rpm) for approxiamtely 6 hours at 37C. The growth medium, L-broth, consist of the following ingredients dissolved in 1 L of distilled water and adjusted to pH 7.0: tryptone 10 g, yeast extract 5 g, sodium chloride 10 g, glucose 1 g. This culture is diluted in sterile L-broth to 50% T @ 660 mu, further diluted 1:10, and inoculated at a ratio of 1:100 into molten soybean-casein digest agar medium (Inolex) maintained at 45-50C. Assay plates are prepared by first pipesetting a 5 ml base layer of soybean-casein digest agar medium (TSA), allowing this to harden at room temperature in disposable petri dishes, and then overlaying with 5 ml of seeded TSA. These preparations are used the same day.
, .
~51~8 Coated polyethylene films (prepared in the manner taught in the Example below) are tested in the same way regardless of the antimicrobial incorporated into the adhesive layer. Ten o mm discs are cut from an evenly coated area (i.e. no visible flaws) with a heavy duty paper punch (Master Products, Series 25). The paper backing is removed from the coated disc with the aid of forceps and microspatula. The coated disc is then placed adhesive-side down on the seeded-agar surface, 4 per plate.
Iodine reference discs are then prepared. A
solution containing 10 percent iodine is prepared by dissolving 1 g of iodine and 1 g of sodium iodide in 10 percent aqueous acetone using a 10 ml volumetric flask.
This stock solution, freshly prepared and the same solvent is used to prepare 0.~5, 0.5, 0.75 and 1.0 percent iodine solutions. From these dilutions, 10 uI aliquots are applied to 6 mm polyester fabric discs placed on the seeded agar surface to provide discs containing 25, 50, 75 and 100 ug iodine each. IThe polyester fabric should be leached overnight in solvent to remove inherent antibacterial activity prior to punching ) Each reference disc is covered with a 1 inch square of 2-ml polyethylene to prevent vaporization prior to diffusion through the underlying agar.
The coated discs and reference disc assay plates are incubated overnight at room temperature. Zones of inhibition around the discs were measured to the nearest 0.5 mm with the aid of a binocular stereoscopic microscope. In the case of iodine antimicrobials, the coated discs are also removed to examine plates for areas of growth inhibition under the discs.
Assay results for reference antimicrobials using the preceding methods demonstrate that the diameter of the zone of inhibition measured in mm is linearly proportional to LOGlo concentration for each agent over the range examined. The release of antimicrobial from the adhesive S41~
of the present invention can be estimated by graphic interpolation oE the inhibition values.
The starch test is performed as follows: An dicator solution is prepared by dissolving 62.5 g of .i " ~`~ qd~ ~
~ Iodine Titration Indicator (Eastern Chemical, Division of Guardian Chemical Corp., Hauppauge, N~) is dissolved in 250 ml of distilled water with stirring. A
drop of the Paragon Indicator solution from then is placed on the adhesive surface. Formation of blue coloration in the drop indicates availability of iodine.
The process for forming the composition of the present invention involves forming a pressure sensitive adhesive and mixing into it an antimicrobial treating solution comprising iodine, an iodide, and a solvent. The resulting composition preferably contains N-vinyl-pyrrolidone (NVP) in the backbone of the pressure-sensitive adhesive which serves to complex iodine. It is believed that complexation provides stability while maintaining an appropriate equilibrium to provide sustained release of iodine.
The composition which is the resulting chemical complex of the aforementioned process is stable, non-irritating, non-sensitizing, non-toxic and non-trauma-tizing to skin or other tissues. Although it is generally recognized that an acid medium renders many broad-spectrum antimicrobial agents more stable, i.e.
PVP-I, it has been found that a pressure sensitive adhesive having a significant acidic content causes a negative alteration in the stability of iodine in the present system. Therefore it is desirable that the normally room temperature tacky pressure-sensitive adhesive monomers which is to act as the base of the present composition be substantially free of acidic components. By "substantially free of acidic components"
it is meant that the pressure-sensitive adhesive monomers be substantially free of substituent groups which exhibit acid functionality, e.g., acrylic acid~ etc. Examples of ~ f~fJ,cfe M,3~k s~
adhesive monomer which can be utilized in the preparation present antimicrobial composition PSA include acrylics and vinyl/acrylics. The formulation of these adhesives are well known in the art, e.g. U.S. Patents RE 24906, 2,973,286, 3,307,544, 3,728,148, etc. It will be appreciated by one skilled in the art that the aforestated adhesive types might also include various chemical modifiers so as to enable them to have the utility dictated by the situation, e.y. tackifiers, crosslinkers, stabili2ers, initiators etc. The preferred pressure sensitive adhesive for use in this invention is a copolymer comprised of N-vinylpyrrolidone (NVP) and isooctyl acrylate (IOA).
It is believed that the iodine release is controlled by the copolymerization of low levels of the NVP into the adhesive backbone. The iodine release from the adhesive matrix is a function of the level of NVP
copolymerized into the adhesive backbone. For a given iodine content, the higher the NVP level, the lower the antimicrobial activity~ For this invention, the useful NVP comonomer level is less than 30% (preferentially 5-10%) of the total adhesive solids. At higher ~VP
levels, skin adhesion and antimicrobial activity are - reduced.
An antimicrobial solution is used to incorporate iodine into the pressure sensitive adhesive. This solution contains iodine, inorganic iodide (e.g., potassium iodide) and a suitable solvent compatible with the adhesive. A solution recommended for use with the 5-10% NVP copolymer adhesive above would have a ~.5:1 to 4:1 molar ratio of iodide:iodine dissolved in denatured ethanol (preferred solution, 2:1 molar ratio of iodide:iodine). For example, a solution utilizing sodium iodide would have a formulation of 1-20 wt.% iodine, 1.2-24 wt.~; sodium iodide and 97.8-56 wt.% ethanol.
Although the mechanism of complexation of iodine into the aclhesive matrix of this invention is not 15~8 completely understood, it is believed to have some analogy to the complexation of iodine with polyvinylpyrrolidone.
The following is one possible representation of the complex of the present invention:
5 / IOR ~ ~ ~ C=~ ~ OR ~ ¦ ~ C=o~
C=OI N ~ ~1 C=o~
~CH2-CH-~L - -CH2-CH---/ CH2-CH-~ CH2-CH~
where m, n, o and p are integers.
The composition of the process of the present invention may be either attached directly onto a flexible backing substrate or ~ormed onto a release liner for later use. The backing may be any material known for use in medical application with the preferred material being polyethylene film. The solvents are then evaporated by means known to the art whereby an adhesive film is formed which is useable in or on tapes, drapes and other medical 15 devices.
The invention is further illustrated by the following non-limiting example:
A solution polymer adhesive of composition isooctyl acrylate/N-vinylpyrrolidone/ -methacryloxypropyl trimethoxysilane (94.95/5/0.05) is prepared by polymeriza-tion in ethyl acetate/heptane/ethanol (48/47/5) (Conditions: nitrogen atmosphere, azobisisobutyronitrile initiator, 6 hours at 53C; Properties: total solids =
45%, intrinsic viscosity = 0.8).
25 The following formulation is prepared:
adhesive from above 500 g.
a solution containing 20 wt.% iodine/24 wt.%
sodium iodide in denatured ethanol 11 g.
additional denatured ethanol 78 g.
30 a 10 wt.% solution of p-toluenesulfonic acid (p-TSA) in denatured ethanol (0.1 wt.%
p-TSA on adhesive solids) 2.3 g.
5~8 The formulation is stirred at room temperature with a spatula to yield a uniform solution of 1 wt.% iodine/1.2 wt.% sodium iodide on adhesive solids. This solution is coated onto a silicone release liner and dried (10 min., 175F) to form a homogeneous, iodine-colored adhesive film of coating weight equal to 11 grains/24 sq. in. The adhesive film is laminated to a backing of a corona and quatarnary amine antistat treated polyethylene to form a construction containing the antimicrobial iodine. This construction exhibited an activity when applied in vivo on seeded human skin of a four ~4) log reduction of Staph~lococcus aureus and Pseudomonas aeruginosa after one hour. The construction exhibited satisfactory adhesion and stability after sterilization by irradiation.
Claims (7)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for making a composition which exhibits controlled and sustained antiseptic broad-spectrum antimicrobial activity when placed in con-tact with the skin comprising forming a solution of an iodide, a solvent and iodine, and reacting said solution with a dermatologically acceptable pressure-sensitive adhesive.
2. A composition which exhibits antiseptic broad-spectrum antimicrobial activity when placed in contact with the skin comprising a stable chemical complex of an iodide, iodine and a dermatologically acceptable pressure-sensitive adhesive.
3. The composition of claim 2 wherein said dermatologically acceptable pressure-sensitive adhesive is substantially free of acidic components.
4. A flexible sheet material having attached thereto a composition comprising a stable chemical complex of an iodide, iodine and a dermatologically acceptable pressure-sensitive adhesive.
5. The composition of claim 2 or 4 wherein said pressure-sensitive adhesive is a copolymer comprising isooctyl arylate and N-vinyl-pyrrolidone.
6. A process in accordance with claim 1 wherein said pressure-sensitive adhesive is substantially free of acidic components.
7. A process in accordance with claim 1 or 6 wherein said pressure-sensi-tive adhesive is a copolymer comprising N-vinyl pyrrolidone and isooctyl acrylate.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62,362 | 1979-07-31 | ||
US06/062,362 US4323557A (en) | 1979-07-31 | 1979-07-31 | Pressure-sensitive adhesive containing iodine |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1151548A true CA1151548A (en) | 1983-08-09 |
Family
ID=22041975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000354628A Expired CA1151548A (en) | 1979-07-31 | 1980-06-23 | Pressure-sensitive adhesive containing iodine |
Country Status (8)
Country | Link |
---|---|
US (1) | US4323557A (en) |
EP (1) | EP0024107B2 (en) |
JP (2) | JPS5622727A (en) |
AU (1) | AU537351B2 (en) |
CA (1) | CA1151548A (en) |
DE (1) | DE3065603D1 (en) |
ES (1) | ES493775A0 (en) |
ZA (1) | ZA804631B (en) |
Families Citing this family (248)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0011471B1 (en) * | 1978-11-17 | 1983-02-09 | SMITH & NEPHEW RESEARCH LIMITED | Adhesive-coated sheet material incorporating anti-bacterial substances |
US4323557A (en) * | 1979-07-31 | 1982-04-06 | Minnesota Mining & Manufacturing Company | Pressure-sensitive adhesive containing iodine |
SU1170663A1 (en) * | 1983-04-14 | 1987-04-23 | Всесоюзный научно-исследовательский и испытательный институт медицинской техники | Compound for joning tissues and organs |
JPS6041968A (en) * | 1983-08-19 | 1985-03-05 | 日東電工株式会社 | Hydrophilic drug member |
EP0163653A4 (en) * | 1983-11-29 | 1987-01-10 | Avtex Fibers Inc | Microbicidal materials. |
US4584192A (en) * | 1984-06-04 | 1986-04-22 | Minnesota Mining & Manufacturing Company | Film-forming composition containing an antimicrobial agent and methods of use |
US4904247A (en) * | 1984-08-31 | 1990-02-27 | Kendall Company | Pressure-sensitive hydrophilic laminate structures for use in wound dressing, transdermal and topical drug delivery |
US4685455A (en) * | 1984-10-16 | 1987-08-11 | Akzo Nv | Watervapor-permeable, pressure sensitive, antiseptic wound covering material |
AU563054B2 (en) * | 1984-10-24 | 1987-06-25 | Sekisui Kagaku Kogyo Kabushiki Kaisha | Percutaneous tape of isdn |
US4643180A (en) * | 1985-02-28 | 1987-02-17 | Surgikos, Inc. | Antimicrobial dressing |
US4693776A (en) * | 1985-05-16 | 1987-09-15 | Minnesota Mining And Manufacturing Company | Macromer reinforced pressure sensitive skin adhesive |
US4732808A (en) * | 1985-11-14 | 1988-03-22 | Minnesota Mining And Manufacturing Company | Macromer reinforced pressure sensitive skin adhesive sheet material |
US4643181A (en) * | 1986-04-04 | 1987-02-17 | Surgikos, Inc. | Antimicrobial dressing or drape material |
US4788971A (en) * | 1987-07-13 | 1988-12-06 | Hill Top Research, Inc. | Patch system for use on the skin |
NL8702275A (en) * | 1987-09-24 | 1989-04-17 | Avery International Corp | PRESSURE SENSITIVE ADHESIVE. |
US4812305A (en) * | 1987-11-09 | 1989-03-14 | Vocal Rodolfo S | Well medicine strip |
US4931282A (en) * | 1987-11-25 | 1990-06-05 | Minnesota Mining And Manufacturing Company | Pressure-sensitive medical sealant |
US4985235A (en) * | 1988-08-02 | 1991-01-15 | Kligman Albert M | Treatment of periodontoclasia with retinoic acid |
US5071648A (en) * | 1989-04-06 | 1991-12-10 | Merocel Corporation | Polymeric broad-spectrum antimicrobial materials |
US4978527A (en) * | 1989-04-10 | 1990-12-18 | Minnesota Mining And Manufacturing Company | Film-forming emulsion containing iodine and methods of use |
MY105521A (en) * | 1989-04-17 | 1994-10-31 | Healthpoint Ltd | Moisturizing vehicle for topical application of vitamin a acid. |
ATE142557T1 (en) * | 1989-05-11 | 1996-09-15 | Landec Corp | TEMPERATURE ACTIVATED BINDER UNITS |
US5156911A (en) * | 1989-05-11 | 1992-10-20 | Landec Labs Inc. | Skin-activated temperature-sensitive adhesive assemblies |
US5045601A (en) * | 1989-06-13 | 1991-09-03 | Biointerface Technologies, Inc. | Pressure-sensitive adhesive compositions suitable for medical uses |
US5409472A (en) * | 1989-08-03 | 1995-04-25 | Smith & Nephew Plc | Adhesive polymeric foam dressings |
US5197493A (en) * | 1989-12-14 | 1993-03-30 | Kimberly-Clark Corporation | Incise system |
GB9006346D0 (en) * | 1990-03-21 | 1990-05-16 | Euro Celtique Sa | Pharmaceutical composition |
US5069907A (en) * | 1990-03-23 | 1991-12-03 | Phoenix Medical Technology | Surgical drape having incorporated therein a broad spectrum antimicrobial agent |
US5258421A (en) * | 1991-03-20 | 1993-11-02 | Hydromer, Inc. | Method for making tacky, hydrophilic gel dressings |
US5156601A (en) * | 1991-03-20 | 1992-10-20 | Hydromer, Inc. | Tacky, hydrophilic gel dressings and products therefrom |
GB9117256D0 (en) * | 1991-08-09 | 1991-09-25 | Smith & Nephew | Adhesive products |
US5232838A (en) * | 1991-12-09 | 1993-08-03 | Minnesota Mining And Manufacturing Company | Culture media device and method of use |
EP0662783B1 (en) * | 1992-09-22 | 1997-07-23 | Arda Technologies, Co. | Antimicrobial composition and method of preparation |
NZ248977A (en) * | 1992-11-09 | 1995-06-27 | Squibb & Sons Inc | Pressure-sensitive adhesive comprising a polyurethane having excess hydroxyl functionality; medical articles comprising a layer of such adhesive |
US5407368A (en) * | 1992-12-15 | 1995-04-18 | Minnesota Mining And Manufacturing Company | Electrode connector |
US5454739A (en) * | 1992-12-15 | 1995-10-03 | Minnesota Mining And Manufacturing Company | Electrode connector |
CA2157040C (en) | 1993-03-22 | 2007-12-11 | Steven B. Heinecke | Windowless frame delivered dressing and method of manufacture |
US6685682B1 (en) | 1993-03-22 | 2004-02-03 | 3M Innovative Properties Company | Carrier delivered dressing and method of manufacture |
US5420197A (en) * | 1994-01-13 | 1995-05-30 | Hydromer, Inc. | Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives |
WO1996019921A1 (en) * | 1994-12-23 | 1996-07-04 | Commonwealth Scientific And Industrial Research Organisation | Iodine biocidal material |
US5660823A (en) * | 1995-10-11 | 1997-08-26 | Isp Investments Inc. | Fast drying, film forming iodine release solution |
US5736228A (en) * | 1995-10-25 | 1998-04-07 | Minnesota Mining And Manufacturing Company | Direct print film and method for preparing same |
US5827184A (en) * | 1995-12-29 | 1998-10-27 | Minnesota Mining And Manufacturing Company | Self-packaging bioelectrodes |
EP0910303B1 (en) * | 1996-05-16 | 2002-03-20 | Minnesota Mining And Manufacturing Company | Surgical incise drape |
US5803086A (en) * | 1996-05-16 | 1998-09-08 | Minnesota Mining And Manufacturing Company | Linerless surgical incise drape |
US20080078413A1 (en) * | 1996-06-12 | 2008-04-03 | Padget David B | Surgical drape |
US20040234605A1 (en) * | 1996-06-12 | 2004-11-25 | Cox David D. | Antimicrobial adhesive system |
US5829442A (en) | 1996-06-12 | 1998-11-03 | Medical Concepts Development, Inc. | Antimicrobial containing solventless hot melt adhesive composition |
EP1249354A1 (en) | 1996-06-14 | 2002-10-16 | Minnesota Mining And Manufacturing Company | Display unit and methods of displaying an image |
JP2000513608A (en) * | 1996-07-02 | 2000-10-17 | ミネソタ マイニング アンド マニュファクチャリング カンパニー | Packaged medical adhesive composite |
USD410087S (en) | 1996-07-02 | 1999-05-18 | Dunshee Wayne K | Adhesive bandage |
US5976117A (en) * | 1996-09-25 | 1999-11-02 | 3M Innovative Properties Company | Wound dressing |
DE19649237A1 (en) * | 1996-11-28 | 1998-06-04 | Bluecher Gmbh | Agent with antiseptic activity, which produces iodine vapour |
US5684042A (en) * | 1997-01-10 | 1997-11-04 | Medlogic Global Corporation | Cyanoacrylate compositions comprising an antimicrobial agent |
CA2317413A1 (en) | 1997-01-10 | 1998-07-16 | Medlogic Global Corporation | Cyanoacrylate compositions comprising an antimicrobial agent |
US6018092A (en) * | 1997-03-04 | 2000-01-25 | 3M Innovative Properties Company | Medical adhesive bandage, delivery system and method |
EP0983094A1 (en) * | 1997-05-06 | 2000-03-08 | Minnesota Mining And Manufacturing Company | Textured, matte-finish, low adhesion coatings |
CA2288019C (en) | 1997-05-16 | 2008-01-22 | Minnesota Mining And Manufacturing Company | Surgical incise drape |
US6420622B1 (en) | 1997-08-01 | 2002-07-16 | 3M Innovative Properties Company | Medical article having fluid control film |
US6007532A (en) | 1997-08-29 | 1999-12-28 | 3M Innovative Properties Company | Method and apparatus for detecting loss of contact of biomedical electrodes with patient skin |
US6096428A (en) * | 1998-04-09 | 2000-08-01 | 3M Innovative Properties Company | Multi-layer compositions comprising a fluoropolymer |
US6156400A (en) | 1998-04-09 | 2000-12-05 | 3M Innovative Properties Company | Multi-layer compositions comprising a fluoropolymer |
USD409754S (en) * | 1998-04-13 | 1999-05-11 | Dunshee Wayne K | Bandage |
USD408541S (en) * | 1998-04-13 | 1999-04-20 | Dunshee Wayne K | Bandage and bandage with carrier |
US6221198B1 (en) | 1998-06-09 | 2001-04-24 | 3M Innovative Properties Company | Method of stabilizing films or membranes using adhesive as a reservoir |
US6607799B1 (en) | 1998-10-15 | 2003-08-19 | 3M Innovative Properties Company | Surgical dressing with delivery system and method of manufacture |
US6356779B1 (en) | 1999-06-04 | 2002-03-12 | 3M Innovative Properties Company | Universally functional biomedical electrode |
US6232366B1 (en) | 1999-06-09 | 2001-05-15 | 3M Innovative Properties Company | Pressure sensitive conductive adhesive having hot-melt properties and biomedical electrodes using same |
US6365169B1 (en) | 1999-09-30 | 2002-04-02 | Solomon Rosenblatt | Polymeric broad spectrum antimicrobial coatings |
US6579469B1 (en) | 1999-10-29 | 2003-06-17 | Closure Medical Corporation | Cyanoacrylate solutions containing preservatives |
US6264976B1 (en) | 1999-11-29 | 2001-07-24 | 3M Innovative Properties Company | Absorbent pad dressing frame delivery system |
US6831205B2 (en) * | 1999-11-29 | 2004-12-14 | Clozex Medical, Llc | Bandage for wound or incision closure |
JP2003530489A (en) | 1999-12-28 | 2003-10-14 | キンバリー クラーク ワールドワイド インコーポレイテッド | Wipes containing controlled release antimicrobial agents |
CA2393542C (en) | 1999-12-28 | 2011-08-16 | Kimberly-Clark Worldwide, Inc. | Use-dependent indicator system for absorbent articles |
ATE396038T1 (en) | 1999-12-28 | 2008-06-15 | Kimberly Clark Co | ANTIMICROBIAL WIPE WITH CONTROLLED RELEASE FOR HARD SURFACES |
ATE318566T1 (en) | 2000-03-10 | 2006-03-15 | 3M Innovative Properties Co | MEDICAL WOUND DRESSING WITH MULTIPLE ADHESIVES AND MANUFACTURING METHODS |
US6379702B1 (en) | 2000-07-05 | 2002-04-30 | Hydromer, Inc. | Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives |
US6903243B1 (en) | 2000-09-08 | 2005-06-07 | 3M Innovative Properties Company | Multi-layer absorbent wound dressing |
US6797743B2 (en) * | 2000-09-27 | 2004-09-28 | Michigan Biotechnology Institute | Antimicrobial polymer |
US6664309B2 (en) | 2000-12-07 | 2003-12-16 | Bostik Findley, Inc. | Antimicrobial hot melt adhesive |
US6531206B2 (en) * | 2001-02-07 | 2003-03-11 | 3M Innovative Properties Company | Microstructured surface film assembly for liquid acquisition and transport |
US6709716B2 (en) | 2001-04-27 | 2004-03-23 | 3M Innovative Properties Company | Microemulsion compositions and methods of making and using same |
JP2005503189A (en) | 2001-05-04 | 2005-02-03 | スリーエム イノベイティブ プロパティズ カンパニー | Corrosion prevention in biomedical electrodes |
US6731965B2 (en) | 2001-06-20 | 2004-05-04 | 3M Innovative Properties Company | Corrosion prevention in biomedical electrodes |
US6602496B2 (en) | 2001-07-05 | 2003-08-05 | Closure Medical Corporation | Adhesive treatment for tinea corporis |
US6942875B2 (en) * | 2001-07-05 | 2005-09-13 | Closure Medical Corporation | Adhesive treatment for skin yeast infections |
US6746667B2 (en) | 2001-07-05 | 2004-06-08 | Closure Medical Corporation | Adhesive treatment for tinea pedis |
US6767552B2 (en) | 2001-07-05 | 2004-07-27 | Closure Medical Corporation | Adhesive treatment for oral fungal infection |
US6585967B2 (en) | 2001-07-05 | 2003-07-01 | Closure Medical Corporation | Adhesive treatment for tinea cruris |
US6902740B2 (en) * | 2001-07-09 | 2005-06-07 | 3M Innovative Properties Company | Pyrrolidonoethyl (meth)acrylate containing pressure sensitive adhesive compositions |
US7063887B2 (en) | 2002-02-04 | 2006-06-20 | 3M Innovative Properties Company | Stretch releasable foams, articles including same and methods for the manufacture thereof |
US20030175497A1 (en) * | 2002-02-04 | 2003-09-18 | 3M Innovative Properties Company | Flame retardant foams, articles including same and methods for the manufacture thereof |
US6939554B2 (en) * | 2002-02-05 | 2005-09-06 | Michigan Biotechnology Institute | Antimicrobial polymer |
WO2003080730A1 (en) | 2002-03-20 | 2003-10-02 | Michigan Biotechnology Institute | Conductive polymer-based material |
US6708050B2 (en) | 2002-03-28 | 2004-03-16 | 3M Innovative Properties Company | Wireless electrode having activatable power cell |
US7181875B2 (en) | 2002-03-29 | 2007-02-27 | 3M Innovative Properties Company | Stock material for trim caps |
US6866928B2 (en) | 2002-04-08 | 2005-03-15 | 3M Innovative Properties Company | Cleanly removable tapes and methods for the manufacture thereof |
US6939936B2 (en) * | 2002-04-25 | 2005-09-06 | 3M Innovative Properties Company | Iodine/iodide-containing hot melt coatable adhesive, methods and uses therefor |
US6803090B2 (en) | 2002-05-13 | 2004-10-12 | 3M Innovative Properties Company | Fluid transport assemblies with flame retardant properties |
US6923320B2 (en) * | 2002-07-06 | 2005-08-02 | Victor A. Grossman | Bandage package and dispenser |
US6951902B2 (en) * | 2002-08-16 | 2005-10-04 | Michigan Biotechnology Institute | Two dimensional polymer that generates nitric oxide |
US6838589B2 (en) | 2003-02-19 | 2005-01-04 | 3M Innovative Properties Company | Conformable wound dressing |
US7229683B2 (en) * | 2003-05-30 | 2007-06-12 | 3M Innovative Properties Company | Thermal interface materials and method of making thermal interface materials |
US7744991B2 (en) * | 2003-05-30 | 2010-06-29 | 3M Innovative Properties Company | Thermally conducting foam interface materials |
US9278155B2 (en) * | 2003-06-05 | 2016-03-08 | 3M Innovative Properties Company | Adhesive compositions, articles incorporating same and methods of manufacture |
US20040247654A1 (en) * | 2003-06-05 | 2004-12-09 | 3M Innovative Properties Company | Hydrophilic adhesives for delivery of herbal medicines |
US7354446B2 (en) * | 2003-07-24 | 2008-04-08 | Clozex Medical, Llc | Device for laceration or incision closure |
US7414168B2 (en) * | 2003-07-24 | 2008-08-19 | Clozex Medical Llc | Device for laceration or incision closure |
US7838718B2 (en) * | 2003-07-24 | 2010-11-23 | Clozex Medical, Llc | Device for laceration or incision closure |
US8636763B2 (en) * | 2003-07-24 | 2014-01-28 | Clozex Medical, Llc | Device for laceration or incision closure |
US20050021081A1 (en) * | 2003-07-24 | 2005-01-27 | Clozex Medical, Llc | Device for laceration or incision closure |
USD495419S1 (en) | 2003-08-15 | 2004-08-31 | 3M Innovative Properties Company | Bandage |
US7332641B2 (en) * | 2003-10-10 | 2008-02-19 | Clozex Medical Llc | Interlaced compositions and methods of production |
US20050106360A1 (en) | 2003-11-13 | 2005-05-19 | Johnston Raymond P. | Microstructured surface building assemblies for fluid disposition |
US20050130527A1 (en) * | 2003-12-11 | 2005-06-16 | 3M Innovative Properties Company | UV stabilized fibrous articles and method of making the same |
US20050249791A1 (en) * | 2004-05-07 | 2005-11-10 | 3M Innovative Properties Company | Antimicrobial articles |
US20060035039A1 (en) * | 2004-08-12 | 2006-02-16 | 3M Innovative Properties Company | Silver-releasing articles and methods of manufacture |
US20060034899A1 (en) * | 2004-08-12 | 2006-02-16 | Ylitalo Caroline M | Biologically-active adhesive articles and methods of manufacture |
US7563941B2 (en) * | 2004-09-10 | 2009-07-21 | Clozex Medical, Llc | Modular wound dressing system |
US7781041B2 (en) | 2004-11-19 | 2010-08-24 | Beekley Corporation | Tattoo cover and related method |
US7506760B2 (en) * | 2005-01-10 | 2009-03-24 | Grossman Victor A | Packaging and dispensers for adhesive backed elements |
USD559985S1 (en) | 2005-04-08 | 2008-01-15 | Beekley Corporation | Mammogram marker |
USD590949S1 (en) * | 2005-06-30 | 2009-04-21 | Beekley Corporation | Temporary tattoo cover |
US20070010777A1 (en) * | 2005-07-06 | 2007-01-11 | 3M Innovative Properties Company | Medical tape and bandages |
US20070038246A1 (en) * | 2005-08-09 | 2007-02-15 | Clozex Medical, Llc | Four component wound closure device with locking strip |
US8105353B2 (en) | 2005-08-09 | 2012-01-31 | Clozex Medical, Llc | Wound closure kit and method of using the same |
US7442849B2 (en) * | 2005-12-30 | 2008-10-28 | 3M Innovative Properties Company | Thin film delivery system and method of manufacture |
US20090186332A1 (en) * | 2006-03-15 | 2009-07-23 | Manders Ernest K | Preparation and storage of stable, antimicrobially active materials |
US20070243258A1 (en) * | 2006-04-13 | 2007-10-18 | 3M Innovative Properties Company | Method and apparatus for forming crosslinked chromonic nanoparticles |
USD611156S1 (en) | 2006-06-12 | 2010-03-02 | 3M Innovative Properties Company | Bandage |
US7858838B2 (en) * | 2006-08-10 | 2010-12-28 | 3M Innovative Properties Company | Conformable wound dressing |
US20080200890A1 (en) * | 2006-12-11 | 2008-08-21 | 3M Innovative Properties Company | Antimicrobial disposable absorbent articles |
US9555167B2 (en) * | 2006-12-11 | 2017-01-31 | 3M Innovative Properties Company | Biocompatible antimicrobial compositions |
US8729121B2 (en) * | 2007-06-25 | 2014-05-20 | Adhezion Biomedical, Llc | Curing accelerator and method of making |
EP2211727B1 (en) | 2007-11-14 | 2014-03-12 | Adhezion Biomedical, LLC | Cyanoacrylate tissue adhesives |
CA2711177A1 (en) * | 2007-12-31 | 2009-07-16 | 3M Innovative Properties Company | Medical dressing with edge port and methods of use |
US9242022B2 (en) * | 2008-01-18 | 2016-01-26 | 3M Innovative Properties Company | Hydrogels with tapered edge |
BRPI0906549A8 (en) * | 2008-04-04 | 2019-02-12 | 3M Innovative Properties Co | medical bandage |
US20110112492A1 (en) | 2008-04-04 | 2011-05-12 | Vivek Bharti | Wound dressing with micropump |
JP2011518222A (en) * | 2008-04-21 | 2011-06-23 | スリーエム イノベイティブ プロパティズ カンパニー | Nitric oxide releasing composition, device and method |
WO2009143249A2 (en) * | 2008-05-23 | 2009-11-26 | 3M Innovative Properties Company | Grounding electrode |
CA2727427A1 (en) | 2008-06-12 | 2009-12-17 | 3M Innovative Properties Company | Melt blown fine fibers and methods of manufacture |
AU2009257361A1 (en) | 2008-06-12 | 2009-12-17 | 3M Innovative Properties Company | Biocompatible hydrophilic compositions |
US8198344B2 (en) | 2008-06-20 | 2012-06-12 | Adhezion Biomedical, Llc | Method of preparing adhesive compositions for medical use: single additive as both the thickening agent and the accelerator |
US8293838B2 (en) * | 2008-06-20 | 2012-10-23 | Adhezion Biomedical, Llc | Stable and sterile tissue adhesive composition with a controlled high viscosity |
US20110117047A1 (en) | 2008-06-23 | 2011-05-19 | Adhezion Biomedical, Llc | Cyanoacrylate tissue adhesives with desirable permeability and tensile strength |
US9457123B2 (en) * | 2008-09-24 | 2016-10-04 | 3M Innovative Properties Company | Hydrogels with release element |
JP5421379B2 (en) * | 2008-09-30 | 2014-02-19 | スリーエム イノベイティブ プロパティズ カンパニー | Thin film nasal dilator with delivery system |
MX2011004294A (en) * | 2008-10-24 | 2011-05-23 | 3M Innovative Properties Co | Conformable wound dressing. |
US8110718B2 (en) * | 2008-10-27 | 2012-02-07 | 3M Innovative Properties Company | Thin film delivery system and method of manufacture |
US8609128B2 (en) | 2008-10-31 | 2013-12-17 | Adhezion Biomedical, Llc | Cyanoacrylate-based liquid microbial sealant drape |
US9254133B2 (en) | 2008-10-31 | 2016-02-09 | Adhezion Biomedical, Llc | Sterilized liquid compositions of cyanoacrylate monomer mixtures |
US8652510B2 (en) | 2008-10-31 | 2014-02-18 | Adhezion Biomedical, Llc | Sterilized liquid compositions of cyanoacrylate monomer mixtures |
US11278740B2 (en) | 2008-11-03 | 2022-03-22 | Berkley Corporation | Temporary tattoo cover and related method |
US10314935B2 (en) | 2009-01-07 | 2019-06-11 | Entrotech Life Sciences, Inc. | Chlorhexidine-containing antimicrobial laminates |
EP2411061B1 (en) | 2009-03-27 | 2014-11-19 | 3M Innovative Properties Company | Hydrophilic polypropylene melt additives |
EP2414574B1 (en) | 2009-03-31 | 2018-12-12 | 3M Innovative Properties Company | Dimensionally stable nonwoven fibrous webs and methods of making and using the same |
CN104095709B (en) | 2009-06-16 | 2017-06-13 | 3M创新有限公司 | Conformable Medical with self-supporting substrate |
WO2011022525A1 (en) | 2009-08-21 | 2011-02-24 | 3M Innovative Properties Company | Methods and products for illuminating tissue |
EP2467081A4 (en) | 2009-08-21 | 2015-05-06 | 3M Innovative Properties Co | Methods and products for reducing tissue trauma using water-absorbing stress-distributing materials |
EP3143943B1 (en) | 2009-08-21 | 2019-02-27 | 3M Innovative Properties Company | Products for reducing tissue trauma using water-resistant stress-distributing materials |
WO2011055388A2 (en) | 2009-11-05 | 2011-05-12 | Indian Institute Of Technology | Wound dressing polymer matrix |
CN102596560B (en) * | 2009-11-09 | 2015-11-25 | 3M创新有限公司 | Medical article and the method using miscible composition to be prepared |
KR20120091339A (en) | 2009-11-09 | 2012-08-17 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | Medical articles and methods of making using immiscible material |
BR112012014945A2 (en) | 2009-12-17 | 2018-10-09 | 3M Innovative Properties Co | dimensionally stable non-woven fibrous mat, meltblown thin fibers, and methods of fabrication and use thereof |
CN105274733B (en) * | 2009-12-17 | 2018-11-20 | 3M创新有限公司 | Non-woven fibre web of dimensionally stable and production and preparation method thereof |
JP2013520583A (en) | 2010-02-23 | 2013-06-06 | スリーエム イノベイティブ プロパティズ カンパニー | Dimensionally stable nonwoven fibrous webs and methods for their manufacture and use |
US9309019B2 (en) | 2010-05-21 | 2016-04-12 | Adhezion Biomedical, Llc | Low dose gamma sterilization of liquid adhesives |
TW201221714A (en) | 2010-10-14 | 2012-06-01 | 3M Innovative Properties Co | Dimensionally stable nonwoven fibrous webs and methods of making and using the same |
CN103281997A (en) | 2010-12-29 | 2013-09-04 | 3M创新有限公司 | An elastic strip |
EP2658492B1 (en) | 2010-12-29 | 2023-11-22 | 3M Innovative Properties Company | An apertured hydrogel |
EP2731563B1 (en) | 2011-07-12 | 2017-05-17 | 3M Innovative Properties Company | A wound dressing assembly |
EP2755620A4 (en) | 2011-09-14 | 2015-06-03 | 3M Innovative Properties Co | Positive pressure medical dressings with valve and kits containing same |
US9220627B2 (en) | 2011-11-30 | 2015-12-29 | Mark Allen Fisher | Abdominal elevator |
KR20140101416A (en) | 2011-12-13 | 2014-08-19 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | Method of making pressure-sensitive adhesive article including active agent |
US20130171203A1 (en) | 2011-12-16 | 2013-07-04 | Solomon Rosenblatt | Composition And Methods For Antimicrobial Articles |
CN104334113A (en) | 2011-12-29 | 2015-02-04 | 3M创新有限公司 | Filled incise drape |
US11944519B2 (en) | 2012-01-18 | 2024-04-02 | Worldwide Innovative Healthcare, Inc. | Unbacked and modifiable tapes and skin dressings |
WO2013162680A1 (en) | 2012-04-23 | 2013-10-31 | 3M Innovative Properties Company | Conforming securement articles and methods of use |
BR112015001280A2 (en) | 2012-07-20 | 2017-07-04 | 3M Innovative Properties Co | fixing set, method for fixing a fixing set and method for fixing a device |
US10342628B2 (en) | 2012-09-21 | 2019-07-09 | 3M Innovative Properties Company | Incision protection |
JP2016504212A (en) | 2012-11-20 | 2016-02-12 | スリーエム イノベイティブ プロパティズ カンパニー | Laminates and articles comprising block copolymer coatings comprising polyorganosiloxane and polyolefin |
WO2014081682A1 (en) | 2012-11-20 | 2014-05-30 | 3M Innovative Properties Company | Block copolymer comprising polyorganosiloxane block and polyolefin block |
EP2934659B1 (en) | 2012-12-21 | 2019-03-06 | 3M Innovative Properties Company | Adhesive assemblies and microneedle injection apparatuses comprising same |
US10434284B2 (en) | 2012-12-21 | 2019-10-08 | 3M Innovative Properties Company | Medical dressing comprising a flap |
CN105188623B (en) | 2013-03-11 | 2020-09-25 | 3M创新有限公司 | Conformable medical dressing |
WO2014209620A1 (en) | 2013-06-28 | 2014-12-31 | 3M Innovative Properties Company | Fibrin-coated wound dressing |
WO2015013093A1 (en) | 2013-07-23 | 2015-01-29 | 3M Innovative Properties Company | Adjustable wound dressing |
WO2015020882A1 (en) | 2013-08-05 | 2015-02-12 | 3M Innovative Properties Company | Catheter securement device |
JP2016533436A (en) | 2013-10-04 | 2016-10-27 | スリーエム イノベイティブ プロパティズ カンパニー | Multicomponent fibers, nonwoven webs, and articles comprising polydiorganosiloxane polyamides |
CN105873549B (en) | 2013-12-31 | 2017-10-27 | 3M创新有限公司 | Conformal drape covering dressing |
WO2015130608A1 (en) | 2014-02-25 | 2015-09-03 | 3M Innovative Properties Company | Medical dressing |
US10209213B2 (en) | 2014-02-27 | 2019-02-19 | 3M Innovative Properties Company | Flexible sensor patch and method of using the same |
US9421297B2 (en) | 2014-04-02 | 2016-08-23 | Adhezion Biomedical, Llc | Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides |
WO2015161302A1 (en) | 2014-04-18 | 2015-10-22 | Entrotech Life Sciences, Inc. | Methods of processing chlorhexidine-containing polymerizable compositions and antimicrobial articles formed thereby |
WO2015179235A1 (en) | 2014-05-23 | 2015-11-26 | 3M Innovative Properties Company | A discontinuous silicone adhesive article |
ES2921990T3 (en) | 2014-09-10 | 2022-09-05 | Bard Inc C R | Protective dressing for a medical device placed on the skin |
US10286100B2 (en) | 2014-10-01 | 2019-05-14 | 3M Innovative Properties Company | Medical dressings comprising fluid management articles and methods of using same |
US10973692B2 (en) | 2014-12-19 | 2021-04-13 | 3M Innovative Properties Company | Viscoelastic wound closure dressing |
CA2971621A1 (en) | 2014-12-19 | 2016-06-23 | 3M Innovative Properties Company | Adhesive article comprising a poly(meth)acrylate-based primer layer and methods of making same |
CN107106833B (en) | 2014-12-22 | 2020-10-16 | 3M创新有限公司 | Biomedical electrodes including discontinuous primer layers |
WO2016109418A1 (en) | 2014-12-30 | 2016-07-07 | 3M Innovative Properties Company | Wound dressing with multiple adhesive layers |
CN107427601B (en) | 2015-03-27 | 2021-08-31 | 3M创新有限公司 | Fibrin compositions, methods and articles for wounds |
US11571490B2 (en) | 2015-06-29 | 2023-02-07 | 3M Innovative Properties Company | Anti-microbial articles and methods of using same |
EP3337545B1 (en) | 2015-08-21 | 2021-01-13 | 3M Innovative Properties Company | Nasogastric tube securement systems |
CN107921238A (en) | 2015-08-21 | 2018-04-17 | 3M创新有限公司 | Nose catheter fixed system and its application method |
CN107949416A (en) | 2015-08-21 | 2018-04-20 | 3M创新有限公司 | Nose catheter fixed system and its application method |
WO2017058628A1 (en) | 2015-09-30 | 2017-04-06 | 3M Innovative Properties Company | Surgical site cover comprising conformable polymeric film and methods of use |
USD804678S1 (en) | 2015-09-30 | 2017-12-05 | 3M Innovative Properties Company | Oval surgical drape with a retraction member |
USD804677S1 (en) | 2015-09-30 | 2017-12-05 | 3M Innovative Properties Company | Surgical drape with a retraction member |
WO2017083482A1 (en) | 2015-11-13 | 2017-05-18 | 3M Innovative Properties Company | Anti-microbial articles and methods of using same |
WO2017083166A1 (en) | 2015-11-13 | 2017-05-18 | 3M Innovative Properties Company | Anti-microbial articles and methods of using same |
US11827754B2 (en) | 2016-10-05 | 2023-11-28 | 3M Innovative Properties Company | Fibrin composition comprising carrier material, method and wound articles |
US10940233B2 (en) | 2016-10-05 | 2021-03-09 | 3M Innovative Properties Company | Fibrinogen composition, method and wound articles |
US11246761B2 (en) | 2016-10-07 | 2022-02-15 | 3M Innovative Properties Company | Conformable wound dressing and delivery system |
EP3528855A1 (en) | 2016-10-19 | 2019-08-28 | 3M Innovative Properties Company | Anti-microbial articles |
WO2018089563A1 (en) | 2016-11-11 | 2018-05-17 | 3M Innovative Properties Company | Trimmable conformable wound dressing |
EP3589345A1 (en) | 2017-03-02 | 2020-01-08 | 3M Innovative Properties Company | Endotracheal tube securement systems and methods of using same |
CN110636820A (en) | 2017-05-19 | 2019-12-31 | 3M创新有限公司 | Medical article securement devices comprising viscoelastic polymers |
US20200146892A1 (en) | 2017-06-22 | 2020-05-14 | 3M Innovative Properties Company | Negative pressure wound therapy article with features |
US11224544B2 (en) | 2017-09-29 | 2022-01-18 | Johnson & Johnson Consumer Inc. | Extensible dressings |
US20190099294A1 (en) | 2017-09-29 | 2019-04-04 | Johnson & Johnson Consumer Inc. | Extensible Dressings |
JP7304868B2 (en) | 2017-10-09 | 2023-07-07 | スリーエム イノベイティブ プロパティズ カンパニー | Fixed dressings with compatible margins |
EP3703635A1 (en) | 2017-10-31 | 2020-09-09 | 3M Innovative Properties Company | Negative pressure wound therapy article |
EP3723682A1 (en) | 2017-12-14 | 2020-10-21 | 3M Innovative Properties Company | Negative pressure wound therapy article with features |
WO2020035811A1 (en) | 2018-08-17 | 2020-02-20 | 3M Innovative Properties Company | Wound dressing system |
US20220017785A1 (en) | 2018-12-12 | 2022-01-20 | 3M Innovative Properties Company | Release inkjet printing ink articles |
EP3894229A1 (en) | 2018-12-12 | 2021-10-20 | 3M Innovative Properties Company | Releasable article manufactured by inkjet printing of an adhesive |
EP3894500A1 (en) | 2018-12-12 | 2021-10-20 | 3M Innovative Properties Company | Release inkjet printing ink articles |
US20220112404A1 (en) | 2018-12-31 | 2022-04-14 | 3M Innovative Properties Company | Thermally bondable adhesive tape backing |
US20220175585A1 (en) | 2019-04-01 | 2022-06-09 | 3M Innovative Properties Company | Conformable dressing |
EP3975955B1 (en) | 2019-05-28 | 2023-11-01 | 3M Innovative Properties Co. | Medical dressing for securing a tubiform component of a medical device |
WO2020245721A1 (en) | 2019-06-05 | 2020-12-10 | 3M Innovative Properties Company | Medical dressings with stiffening systems |
JP2022543769A (en) | 2019-08-01 | 2022-10-14 | スリーエム イノベイティブ プロパティズ カンパニー | Antibacterial device for insertion needle |
EP4041163A1 (en) | 2019-10-11 | 2022-08-17 | 3M Innovative Properties Company | Tube securement system |
CN114466675A (en) | 2019-10-29 | 2022-05-10 | 3M创新有限公司 | Pipe fixing adhesive tape |
CN114630876A (en) | 2019-11-04 | 2022-06-14 | 3M创新有限公司 | Reinforced adhesive substrate |
EP4061901A1 (en) | 2019-11-20 | 2022-09-28 | 3M Innovative Properties Company | Medical tapes with high optical clarity when over-taped |
WO2021209846A1 (en) | 2020-04-13 | 2021-10-21 | 3M Innovative Properties Company | Medical adhesive articles having a low effective modulus of elasticity |
US20230277385A1 (en) | 2020-07-16 | 2023-09-07 | 3M Innovative Properties Company | Conformable medical dressing |
US11241902B1 (en) | 2020-09-17 | 2022-02-08 | Temptime Corporation | Environmental history monitor with positional displacement and security features |
JP2023552590A (en) | 2020-12-11 | 2023-12-18 | スリーエム イノベイティブ プロパティズ カンパニー | Perforated tape for medical applications |
WO2022137062A1 (en) | 2020-12-21 | 2022-06-30 | 3M Innovative Properties Company | Dual-sided adhesive tapes with on-demand adhesion |
WO2023031697A1 (en) | 2021-09-01 | 2023-03-09 | 3M Innovative Properties Company | Anti-virus respirator and mask |
WO2023203449A1 (en) | 2022-04-20 | 2023-10-26 | 3M Innovative Properties Company | Stretch to fit bandage |
CN115181208B (en) * | 2022-06-23 | 2023-10-20 | 浙江工业大学 | Medical pressure-sensitive adhesive and pressure-sensitive adhesive tape with iodine slow release function and preparation method thereof |
WO2024023619A1 (en) | 2022-07-28 | 2024-02-01 | 3M Innovative Properties Company | Cover dressing, kit, and method of use |
EP4349311A1 (en) | 2022-10-05 | 2024-04-10 | Gergonne SAS | Thin film dressing with perforations and slits |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE685805C (en) | 1935-04-19 | 1939-12-23 | Du Pont | Adhesive mass, adhesive plaster, etc. Like. For bandage purposes |
US2400389A (en) * | 1942-03-26 | 1946-05-14 | Wingfoot Corp | Film containing iodine |
US2427022A (en) * | 1942-11-07 | 1947-09-09 | Ward Baking Co | Surgical adhesive tape |
US2739922A (en) * | 1952-03-13 | 1956-03-27 | Herman A Shelanski | Mixtures of polymeric n-vinyl pyrrolidone and halogens |
US2752281A (en) * | 1953-06-01 | 1956-06-26 | Rohm & Haas | Iodine dissolved in aqueous solutions of maleic anhydride-vinyl ether copolymers |
NL91314C (en) * | 1955-09-19 | |||
US2927914A (en) * | 1956-06-28 | 1960-03-08 | Gen Aniline & Film Corp | Crosslinking of vinyl ether polymers with iodine |
US2826528A (en) * | 1957-05-20 | 1958-03-11 | West Laboratories Inc | Halide polyalkylacrylic compositions |
US2951766A (en) * | 1957-07-15 | 1960-09-06 | Le Roy A White | Antiseptic plastic |
US3028300A (en) * | 1960-09-13 | 1962-04-03 | West Laboratories Inc | Germicidal compositions and methods for preparing the same |
US3307544A (en) * | 1963-09-10 | 1967-03-07 | Johnson & Johnson | Surgical pressure-sensitive adhesive sheet with n-tert-butylacrylamide copolymer adhesive |
US3347233A (en) * | 1964-02-06 | 1967-10-17 | Colgate Palmolive Co | Occlusive medicated sheath |
DE1925348U (en) | 1965-08-31 | 1965-10-14 | Karl Altenburger K G | SHELF. |
GB1213295A (en) | 1967-04-27 | 1970-11-25 | Boots Pure Drug Co Ltd | Improvements in therapeutic compositions for topical application |
US3579628A (en) * | 1967-07-03 | 1971-05-18 | Johnson & Johnson | Dressing film |
US3632740A (en) * | 1968-06-13 | 1972-01-04 | Johnson & Johnson | Topical device for the therapeutic management of dermatological lesions with steroids |
NO134790C (en) * | 1968-07-09 | 1984-03-22 | Smith & Nephew | Kleber ,; PRESSURE SENSITIVE, WATERPUME-PERMEABLE PRODUCT FOR SKIN USE BY HUMANS. |
FR2012584A1 (en) * | 1968-07-09 | 1970-03-20 | Smith & Nephew | Surgical and other materials adhering to skin |
US3535774A (en) | 1968-07-09 | 1970-10-27 | Rca Corp | Method of fabricating semiconductor devices |
US3734097A (en) * | 1969-04-01 | 1973-05-22 | Alza Corp | Therapeutic adhesive tape |
US3598123A (en) * | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3907720A (en) * | 1969-11-10 | 1975-09-23 | Gaf Corp | Insoluble porous polymeric iodine complexes useful as bactericides |
US3577516A (en) * | 1969-12-02 | 1971-05-04 | Nat Patent Dev Corp | Preparation of spray on bandage |
US3728148A (en) * | 1969-12-24 | 1973-04-17 | Beiersdorf Ag | Method for the production of electrical pressure sensitive insulating tapes |
US3749772A (en) * | 1970-12-04 | 1973-07-31 | Univ Akron | Dermal protective film |
US3769071A (en) * | 1971-06-04 | 1973-10-30 | Minnesota Mining & Mfg | Pressure sensitive adhesive tape comprising 5-fluorouracil |
US3996934A (en) * | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
US3886268A (en) * | 1972-05-30 | 1975-05-27 | Synergistics | Iodophor-steroid compound pharmaceutical compositions |
US3898326A (en) * | 1973-05-14 | 1975-08-05 | West Laboratories Inc | Polyvinylpyrrolidone-iodide compositions and polyvinylpyrrolidone-iodide-iodine complexes prepared therefrom |
US3969498A (en) * | 1973-09-13 | 1976-07-13 | University Of The Pacific | Dressing and method for treating a wound |
DE2403225B2 (en) | 1974-01-24 | 1979-05-17 | Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt | Process for the production of iodophores |
US3896789A (en) * | 1974-06-10 | 1975-07-29 | Riker Laboratories Inc | Retinoic acid dipensing pressure sensitive dermotological tape |
CH612984A5 (en) | 1974-12-02 | 1979-08-31 | Ciba Geigy Ag | |
DE2557607A1 (en) * | 1974-12-27 | 1976-07-08 | Hydrophilics Int Inc | PRODUCTS AND PHARMACEUTICAL PREPARATIONS CONTAINING IODINE |
SU578971A1 (en) | 1975-04-29 | 1977-11-05 | 2-Й Московский Ордена Ленина Государственный Медицинский Институт Им. Н.И. Пирогова | Wound treatment method |
US4045364A (en) * | 1975-11-24 | 1977-08-30 | American Cyanamid Company | Iodophor soap tissues |
US4113851A (en) * | 1976-04-15 | 1978-09-12 | Leveen Harry H | Microbiocidal composition and articles prepared therefrom |
CA1083481A (en) * | 1976-06-07 | 1980-08-12 | Abraham Cantor | Stabilized iodine tincture |
US4073291A (en) * | 1976-07-28 | 1978-02-14 | Johnson & Johnson | Topical device for administering tretinoin |
US4147775A (en) * | 1976-10-06 | 1979-04-03 | Schwartz Stephen H | Antiseptic composition |
US4094967A (en) * | 1976-10-22 | 1978-06-13 | Allor Foundation | Iodine-polyvinylpyrrolidone solid product and method of preparation |
US4113857A (en) * | 1977-05-16 | 1978-09-12 | The Purdue Frederick Company | Process for the preparation of iodophor compounds and methods for stabilizing iodophor pharmaceutical compositions containing the same |
EP0011471B1 (en) * | 1978-11-17 | 1983-02-09 | SMITH & NEPHEW RESEARCH LIMITED | Adhesive-coated sheet material incorporating anti-bacterial substances |
US4323557A (en) * | 1979-07-31 | 1982-04-06 | Minnesota Mining & Manufacturing Company | Pressure-sensitive adhesive containing iodine |
US4310509A (en) * | 1979-07-31 | 1982-01-12 | Minnesota Mining And Manufacturing Company | Pressure-sensitive adhesive having a broad spectrum antimicrobial therein |
-
1979
- 1979-07-31 US US06/062,362 patent/US4323557A/en not_active Expired - Lifetime
-
1980
- 1980-06-23 CA CA000354628A patent/CA1151548A/en not_active Expired
- 1980-07-02 EP EP80302248A patent/EP0024107B2/en not_active Expired - Lifetime
- 1980-07-02 DE DE8080302248T patent/DE3065603D1/en not_active Expired
- 1980-07-28 ES ES493775A patent/ES493775A0/en active Granted
- 1980-07-29 AU AU60871/80A patent/AU537351B2/en not_active Expired
- 1980-07-30 JP JP10494780A patent/JPS5622727A/en active Granted
- 1980-07-30 ZA ZA00804631A patent/ZA804631B/en unknown
-
1989
- 1989-05-08 JP JP1114896A patent/JPH0643298B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0024107B1 (en) | 1983-11-16 |
EP0024107A1 (en) | 1981-02-25 |
DE3065603D1 (en) | 1983-12-22 |
AU6087180A (en) | 1981-02-05 |
ZA804631B (en) | 1981-07-29 |
JPH0257262A (en) | 1990-02-27 |
AU537351B2 (en) | 1984-06-21 |
JPH0149499B2 (en) | 1989-10-25 |
EP0024107B2 (en) | 1991-01-16 |
ES8106655A1 (en) | 1981-09-01 |
ES493775A0 (en) | 1981-09-01 |
US4323557A (en) | 1982-04-06 |
JPH0643298B2 (en) | 1994-06-08 |
JPS5622727A (en) | 1981-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1151548A (en) | Pressure-sensitive adhesive containing iodine | |
CA1151547A (en) | Pressure-sensitive adhesive having a broad spectrum antimicrobial therein | |
EP0812893B1 (en) | Antimicrobial hot melt adhesive composition | |
US6039940A (en) | Inherently antimicrobial quaternary amine hydrogel wound dressings | |
US6800278B1 (en) | Inherently antimicrobial quaternary amine hydrogel wound dressings | |
JP6433436B2 (en) | Antibacterial adhesive with improved properties | |
JPH02147063A (en) | Antibacterial adhesive component | |
EP1689338B1 (en) | Antimicrobial adhesive system | |
AU761318B2 (en) | Antimicrobial containing solventless hot melt adhesive composition | |
AU2012200831A1 (en) | Antimicrobial adhesive system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |